Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by stockbuphoonon Aug 13, 2020 6:46pm
225 Views
Post# 31405885

RE:RE:RE:Well Q3 here we come where is the partnership???

RE:RE:RE:Well Q3 here we come where is the partnership???

Yes, in order to collect any money from the lawsuit, Liminal has to make some positive progress or else the offer to settle will be tiny (or won't happen at all). If this thing takes off, that will prove 100% that the fraud had been pulled off. 

Is Liminal is going back to Phase 1 to test higher doses as a slow down mechanism because they know they have "penicillin" as John Moran (most credible doctor at company) used to say with efficacy in 5 organs on fibrosis at lower doses? Interesting how this game will turn out. 

They are already talking about going after other indications of Ryplazim if/when they get approved. It's all part of the master scam/plan. Thomvest wins billions and retailers make up their real or paper losses. 

4Justice wrote: Wanted a deal and having the capability to do it are two things... The only thing they did was $ 330 millions losses in 16 months !!!! WOW!

 

<< Previous
Bullboard Posts
Next >>